ENTRY       D11239                      Drug
NAME        Lumretuzumab (USAN/INN)
FORMULA     C6512H10064N1736O2052S44
EXACT_MASS  146824.4235
MOL_WEIGHT  146914.8466
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFR SSYISWVRQA PGQGLEWMGW IYAGTGSPSY
            NQKLQGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARHR DYYSNSLTYW GQGTLVTVSS
            ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
            GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE
            LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            QQGNVFSCSV MHEALHNHYT QKSLSLSPG
            (Light chain)
            DIVMTQSPDS LAVSLGERAT INCKSSQSVL NSGNQKNYLT WYQQKPGQPP KLLIYWASTR
            ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQSDYSY PYTFGQGTKL EIKRTVAAPS
            VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
            LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
            (Disulfide bridge: H22-H96, H147-H203, H223-L220, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'220, H'264-H'324, H'370-H'428, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-HER3 antibody
  TYPE      Monoclonal antibody
TARGET      ERBB3 (HER3) [HSA:2065] [KO:K05084]
  PATHWAY   hsa04012(2065)  ErbB signaling pathway
            hsa05205(2065)  Proteoglycans in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                ERBB3 (HER3)
                 D11239  Lumretuzumab (USAN/INN)
DBLINKS     CAS: 1448327-63-6
            PubChem: 384585217
///
